Christine M. Heske

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplemental Table S1 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Figshare(2024)10.1158/1535-7163.26423707.v1

Top 100%

0DataRank

Top 100%0 citations

Katelyn R. Ludwig, Ariana E. Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh +7 more

Papers

Driven by 24 papers — median percentile 0. Top paper: “Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma”.

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma

Oncogenesis(2020)10.1038/s41389-020-00264-0

N/A

1.2DataRank · unranked

30 citations

Choh Yeung, Sameer H. Issaq, Victor J. Collins, M. Gouzoulis, Yiping Zhang +4 more

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0709

N/A

0.652DataRank · unranked

20 citations

R. Taylor Sundby, Donna Bernstein, John Glod, Rosandra N. Kaplan, Marielle E. Yohe +17 more

Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines

iScience(2024)10.1016/j.isci.2024.109781

N/A

0.373DataRank · unranked

11 citations

Christine M. Heske, Fathi Elloumi, Lőrinc Sándor Pongor, Prashant Khandagale, Sudhir Varma +6 more

Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0225

N/A

0.345DataRank · unranked

9 citations

Christopher J. Ricketts, Laura S. Schmidt, Julia I. Medina, Keita Saito, Lilia Ileva +25 more

Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group

Cancer Medicine(2023)10.1002/cam4.5921

N/A

0.292DataRank · unranked

6 citations

Princess A. Ekpo, Wei Xue, Zhengya Gao, Philip J. Lupo, Rajkumar Venkatramani +2 more

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0428

N/A

0.208DataRank · unranked

3 citations

Elizabeth Stewart, Didier Surdez, Jessica D. Daley, Alice Soragni, Eleni M. Tomazou +24 more

Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line data

STAR Protocols(2025)10.1016/j.xpro.2025.104076

N/A

0.208DataRank · unranked

3 citations

Camille Tlemsani, Christine M. Heske, Lőrinc Sándor Pongor, Prashant Khandagale, Sudhir Varma +6 more

Supplemental Methods from Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

(2023)10.1158/0008-5472.22422704

N/A

0DataRank · unranked

0 citations

Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa +23 more

Supplemental Methods from Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

Figshare(2023)10.1158/0008-5472.22422704.v1

N/A

0DataRank · unranked

0 citations

Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa +23 more

Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy

Frontiers in Oncology(2020)10.3389/fonc.2019.01514

N/A

0DataRank · unranked

102 citations

Christine M. Heske

Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy

Cancers(2024)10.3390/cancers16091648

N/A

0DataRank · unranked

7 citations

Daniel Prior, Christine M. Heske, Juan C. Vasquez, Sophia Zhao

Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0641

N/A

0DataRank · unranked

6 citations

Katelyn R. Ludwig, Ariana E. Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh +7 more

Roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials

Cancer(2024)10.1002/cncr.35457

N/A

0DataRank · unranked

4 citations

Jamie M. Aye, Jacquelyn Crane, Sapna Oberoi, Frank M. Balis, Smita Bhatia +18 more

Supplemental Table S1 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Figshare(2024)10.1158/1535-7163.26423707.v1

Top 100%

0DataRank

Top 100%0 citations

Katelyn R. Ludwig, Ariana E. Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh +7 more

Supplemental Table S1 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

(2024)10.1158/1535-7163.26423707

Top 100%

0DataRank

Top 100%0 citations

Katelyn R. Ludwig, Ariana E. Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh +7 more

Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response

Frontiers in Cell and Developmental Biology(2024)10.3389/fcell.2024.1462840

N/A

0DataRank · unranked

0 citations

Ludmila Szabova, Victor J. Collins, Melanie B. Gordon, Kristine Johnson, Deborah B. Householder +15 more

Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis

European Journal of Cancer(2025)10.1016/j.ejca.2025.115793

N/A

0DataRank · unranked

3 citations

Monika Sparber‐Sauer, Leo Mascarenhas, Johannes H. M. Merks, Ewa Kościelniak, Christine M. Heske +9 more

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2024.7063

N/A

0DataRank · unranked

9 citations

Alyaa Al‐Ibraheemi, Jessica L. Davis, C. Matthew Hawkins, Brian T. Craig, Roshni Dasgupta +26 more

Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0525

N/A

0DataRank · unranked

20 citations

Xiaolin Wan, Edjay R. Hernandez, Ruibai Luo, Gaelyn C. Lyons, Kelli M. Wilson +17 more

Survival outcomes of patients with localized FOXO1 fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Cancer(2020)10.1002/cncr.33334

N/A

0DataRank · unranked

36 citations

Yueh‐Yun Chi, Rajkumar Venkatramani, Minjie Li, Michael Arnold, Roshni Dasgupta +4 more

Results of a phase I trial of ganitumab plus dasatinib in patients with rhabdomyosarcoma (RMS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11561

N/A

0DataRank · unranked

4 citations

Donna Bernstein, John Glod, Rosandra N. Kaplan, John Shern, Marielle E. Yohe +14 more

Evaluating the effects of critical metabolite depletion in pediatric rhabdomyosarcoma (RMS) using a novel inhibitor of nicotinamide phosphoribosyltransferase (NAMPT).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e22004

N/A

0DataRank · unranked

0 citations

Grace B. McKay-Corkum, Choh Yeung, Sameer H. Issaq, Christine M. Heske, Victor J. Collins

Racial and ethnic differences in presentation and clinical outcomes for pediatric rhabdomyosarcoma (RMS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10017

N/A

0DataRank · unranked

0 citations

Senna Munnikhuysen, Wei Xue, Zhengya Gao, Rajkumar Venkatramani, Christine M. Heske +1 more

Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0200

N/A

0DataRank · unranked

13 citations

Victor J. Collins, Choh Yeung, Takeshi Itoh, Sameer H. Issaq, David O. Holland +16 more

Christine M. Heske

Indexed papers

Top data-sharing exemplar

Papers